Anti-BP180 autoantibody levels at diagnosis correlate with 1-year mortality rates in patients with bullous pemphigoid.
Babak Itzinger-MonshiL GulzB PiringerA WialaD KivaranovicM SchmidtA SestiT HeilI VujicC PoschK RappersbergerPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2020)
In bullous pemphigoid, serum concentrations of BP180 autoantibodies at diagnosis could help to identify patients at risk for death within the first year after diagnosis (cut-off value 61 U/mL).